The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Health-related quality of life (HRQoL) in patients (pts) with locally advanced basal cell carcinoma (laBCC) treated with cemiplimab: Analysis of a phase II, open-label clinical trial.
 
Alexander J. Stratigos
Consulting or Advisory Role - Regeneron
Research Funding - Abbvie; Bristol-Myers Squibb; Genesis Pharma; Genesis Pharma; Janssen; Leo Pharma; Lilly; MSD; Novartis; Sanofi
Patents, Royalties, Other Intellectual Property - Color Atlas of Pediatric Dermatology; MacGraw Hill editions
 
Chieh-I Chen
Employment - Regeneron
Stock and Other Ownership Interests - Regeneron
 
Cristina Ivanescu
Employment - IQVIA
Research Funding - Regeneron (Inst)
 
Karl D. Lewis
Honoraria - Array BioPharma; Iovance Biotherapeutics
Consulting or Advisory Role - Array BioPharma; Iovance Biotherapeutics; Merck; Regeneron; Roche; Sanofi
Research Funding - alkermes (Inst); Amgen (Inst); Array BioPharma (Inst); Bristol-Myers Squibb (Inst); Incyte (Inst); Iovance Biotherapeutics (Inst); Kartos Therapeutics (Inst); Merck (Inst); Nektar (Inst); Neon Therapeutics (Inst); OncoSec (Inst); Regeneron (Inst); Replimune (Inst); Roche/Genentech (Inst); Senhwa Biosciences (Inst); Ultimovacs (Inst)
Travel, Accommodations, Expenses - alkermes; Merck; Neon Therapeutics; Regeneron; Roche/Genentech
(OPTIONAL) Uncompensated Relationships - Regeneron; Roche/Genentech
 
Ketty Peris
Speakers' Bureau - Sanofi
 
Oliver Edgar Bechter
Consulting or Advisory Role - Almirall; Bristol-Myers Squibb; Merck Sharp & Dohme; Novartis; Pierre Fabre; Sanofi; Ultimovacs
 
James Harnett
Employment - Regeneron
Stock and Other Ownership Interests - Pfizer; Regeneron
 
Vera Mastey
Employment - Regeneron
Stock and Other Ownership Interests - Regeneron
 
Matthew Reaney
Employment - Sanofi
 
Christina Daskalopoulou
Consulting or Advisory Role - IQVIA
 
Patrick R. LaFontaine
Employment - Sanofi
Stock and Other Ownership Interests - Applied Genetic Technologies Corporation; Neos Therapeutics; Sanofi
 
Gerasimos Konidaris
Employment - Sanofi
 
Denise Bury
Employment - Sanofi
Stock and Other Ownership Interests - Sanofi
 
Suk Young Yoo
Employment - Regeneron
Stock and Other Ownership Interests - Regeneron
 
Kosalai Kal Mohan
Employment - Regeneron
Stock and Other Ownership Interests - Agenus; Amicus Therapeutics; Bellicum Pharmaceuticals; Cel-Sci; Celldex; Gilead Sciences; Merck; Navidea; Newlink Genetics; Progenics; Sarepta Therapeutics; Soligenix; Sorrento Therapeutics; Veracyte
Travel, Accommodations, Expenses - Regeneron
 
Ebony Coates
Employment - Regeneron
Stock and Other Ownership Interests - Regeneron
 
Timothy Geoffrey Bowler
Employment - Regeneron
Stock and Other Ownership Interests - Regeneron
 
Matthew G. Fury
Employment - Regeneron; Regeneron (I)
Stock and Other Ownership Interests - Regeneron; Regeneron (I)
Research Funding - Regeneron
Patents, Royalties, Other Intellectual Property - Regeneorn; Regeneron (I)
 
Aleksandar Sekulic
Research Funding - Genentech (Inst); Regeneron (Inst)